retatrutide nash Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of liver fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming Meet Retatrutide—or as we like
Description
Reductions in glycated hemoglobin (HbA1c) and body weight were the primary goals for evaluating effectiveness, whereas adverse events were used to evaluate safety
Across the five trials, GLP-1 medications had no harmful effect on testosterone levels, the hormones that govern testicular function, sexual function, or sperm quality
60,61 Similarly, a 6-week TRE intervention in middle-aged adults showed no changes in BMD
Manag Care 22 , s176s185 (2016)
Staying lean, strong, and energized is a priority for athletes and very active individuals
Rotating sites : Regularly switching injection sites helps prevent irritation, scarring, and fat tissue changes (lipodystrophy)
